PUSH BACK AGAINST YOUR BIPOLAR DISORDER

Alkermes Pharma Ireland Limited

Application Filed: 2020-09-14
Trademark Application Details
Trademark Logo PUSH BACK AGAINST YOUR BIPOLAR DISORDER

Mark For: PUSH BACK AGAINST YOUR BIPOLAR DISORDER™ trademark registration is intended to cover the categories of providing awareness programs in the nature of educational presentations for patients and caregivers in the field of navigating pharmaceutical treatments for and managing people living with psychiatric diseases and conditions including schizophrenia, depression, major depressive disorder, anxiety, treatment resistant depression, bipolar depression, bipolar disorder, and metabolic diseases including weight gain and dyslipidaemia, none of the foregoing for use with fitness or exercise programs.

Status

2020-09-17 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number90178694
Mark Literal ElementsPUSH BACK AGAINST YOUR BIPOLAR DISORDER
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeService Mark
Current LocationNEW APPLICATION PROCESSING 2020-09-17
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
Primary International Class
  • 044 - Primary Class
  • (Medical, beauty & agricultural) Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameNorm J. Rich
Attorney Docket Number029418-2828

Timeline

2020-09-14Application Filed
2020-09-17Location: NEW APPLICATION PROCESSING
2020-09-17Status: Live/Pending
2020-09-17Status: New application will be assigned to an examining attorney approximately 3 months after filing date.
2020-09-17Transaction Date

Trademark Parties (Applicants & Owners)

Party: Alkermes Pharma Ireland Limited
AddressConnaught House, 1 Burlington Road Dublin 4 IRELAND
Legal Entity TypeCorporation
Legal Entity StateIRELAND

Documents

ApplicationMULTI2020-09-14
DrawingJPEG2020-09-14

Attorney of Record

NORM J. RICH
LARDNER LLP
3000 K STREET, N.W.
SIXTH FLOOR
WASHINGTON, DC 20007

Good, Services, and Codes

International Codes:41
U.S. Codes:100,101,107
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0441Providing awareness programs in the nature of educational presentations for patients and caregivers in the field of navigating pharmaceutical treatments for and managing people living with psychiatric diseases and conditions including schizophrenia, depression, major depressive disorder, anxiety, treatment resistant depression, bipolar depression, bipolar disorder, and metabolic diseases including weight gain and dyslipidaemia, none of the foregoing for use with fitness or exercise programs

Trademark Filing History

DescriptionDateProceeding Number
NEW APPLICATION ENTERED IN TRAM2020-09-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed